Status:
COMPLETED
Comparing the Clinical Performance of BlockBuster vs Proseal-LMA in Unparalysed Patients Undergoing General Anesthesia
Lead Sponsor:
Universiti Kebangsaan Malaysia Medical Centre
Conditions:
Supraglottic Airway Device
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients aged 19 to 78 years with ASA status I-II scheduled for elective surgery under general anesthesia, were recruited and randomized into two groups, Group A (BlockBuster) and Group B (Proseal-LMA...
Detailed Description
This prospective, randomised single-blinded study, was conducted at the operation theatre of Universiti Kebangsaan Malaysia Medical Centre (UKMMC), following approval from the Institutional Ethics Com...
Eligibility Criteria
Inclusion
- age range of 19 to 78 years
- classified as American Society of Anesthesiologists Physical Status (ASA) class I or II
- underwent elective surgery under general anesthesia that required supraglottic airway insertion.
Exclusion
- patients with a body mass index (BMI) over 35 kg/m2.
- patients with limited mouth opening of less than two finger breath of inter-dental gap, edentulous, loose teeth and airway abnormalities.
- patients who at risk of aspiration.
- patients with known allergies to fentanyl and propofol.
Key Trial Info
Start Date :
July 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06058481
Start Date
July 31 2019
End Date
July 31 2020
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia, 56000